drugset / Trial / NCT01359267

Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer

NCT01359267

Phase 0 Completed 12 enrolled University of Chicago
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to obtain preliminary information on the potential of 99m Tc-EC-DG SPECT imaging to distinguish cancer from non cancer.

Timeline

Start
2011-04-19
Primary completion
2015-09-15
Completion
2015-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject TECHNETIUM TC-99M ETHYLENE-DICYSTEINE-DEOXYGLUCOSE Unknown 740 mbq Intravenous

Indications